Landos Biopharma Inc.

NASDAQ: LABP · Real-Time Price · USD
22.93
0.13 (0.57%)
At close: May 23, 2024, 10:00 PM

Landos Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
37.55M 36.64M 8.3M
Short-Term Investments
n/a 7.76M 82.58M
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
n/a n/a 26K
Receivables
n/a n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
491K 851K 1.27M
Total Current Assets
38.04M 45.25M 92.15M
Property-Plant & Equipment
n/a n/a 707K
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
n/a n/a 733K
Total Assets
38.04M 45.25M 92.88M
Account Payables
1.38M 3.44M 12.91M
Deferred Revenue
n/a n/a n/a
Short-Term Debt
n/a n/a n/a
Other Current Liabilities
4.87M 2.69M 3.7M
Total Current Liabilities
6.25M 6.12M 16.61M
Long-Term Debt
n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a
Total Long-Term Liabilities
n/a 3.44M n/a
Total Liabilities
6.25M 6.12M 16.61M
Total Debt
n/a n/a n/a
Common Stock
31K 403K 403K
Retained Earnings
-155.36M -133.43M -94.15M
Comprehensive Income
n/a -57K -225K
Shareholders Equity
31.79M 39.13M 76.27M
Total Investments
n/a 7.76M 82.58M